Back to Schemes

NIPT for fetal sexing (X-linked disorders)

Product Code: 04-NIPT-FSEX-27

From £656.00

Deadline to order: 01/03/2027

NIPT for fetal sexing (X-linked disorders) (plasma).

Target/Genes:

NIPT for the fetal sex determination in the context of X-linked disorders, which often require testing at an early gestational age. 

Technology:

NIPT

Language:

English, French, German, Italian, Spanish

Sample Type:

Plasma (cfDNA)

Accredited:

Yes

Sample dispatch to your laboratory:

Oct-27

Test and Submit Results:

October- November 2027

Final Results and Certificate:

 March 2028

You can complete purchase on our secure partner site.

How it works

Register

  • Enrol before the closing date (01/03/2027)
  • EMQN ships EQA samples or digital cases

Test & submit results

  • Analyse samples in your routine workflow
  • Upload results via your website account (October- November 2027)

Review & get certified

  • EMQN assesses your data
  • Receive your individual results, EQA summary report & certificate of participation ( March 2028)

EQA Assessment

The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy.

Sample Details

Two mock clinical cases with matching samples will be provided. Approximately 1ml of artificial plasma containing approximately 30ng DNA per sample is provided. Complete information will be available in the scheme instructions.

EQA Results

 

Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results. Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

 

Participation Information

Participants are expected to test samples according to their routine strategy and to return a clinical report.

No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc). This EQA is delivered in collaboration with GenQA. 

Enquire about this scheme

Contact Information

added wishlist!
View Wishlist

0

View Wishlist

Register Interest

Express your interest in ''.